These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 18803997

  • 1. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC, Sheng X, Nelson RE, Keskinaslan A, Brixner DI.
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [Abstract] [Full Text] [Related]

  • 2. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 3. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE, Scott LJ.
    Am J Cardiovasc Drugs; 2009 Feb; 9(5):309-30. PubMed ID: 19791840
    [Abstract] [Full Text] [Related]

  • 4. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Feb; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 5. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 7. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED.
    Am J Cardiovasc Drugs; 2009 Aug; 9(6):411-8. PubMed ID: 19929039
    [Abstract] [Full Text] [Related]

  • 8. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP.
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
    Bhad P, Ayalasomayajula S, Karan R, Leon S, Riviere GJ, Sunkara G, Jarugula V.
    J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001
    [Abstract] [Full Text] [Related]

  • 10. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225
    [No Abstract] [Full Text] [Related]

  • 11. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B.
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [Abstract] [Full Text] [Related]

  • 12. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 13. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V, Escobar C.
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
    [Abstract] [Full Text] [Related]

  • 14. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA, Hilleman DE.
    Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
    [Abstract] [Full Text] [Related]

  • 15. Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine.
    Weycker D, Edelsberg J, Vincze G, Kjeldsen SE, Jamerson K, Khan ZM, Oster G.
    J Hum Hypertens; 2007 May; 21(5):374-80. PubMed ID: 17314999
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB.
    Am J Ther; 2010 May; 17(2):188-96. PubMed ID: 19433970
    [Abstract] [Full Text] [Related]

  • 17. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA, Chapman RH, Benner JS, Tang SS, Solomon HA, Joyce A, Foody JM.
    Am J Cardiovasc Drugs; 2010 May; 10(3):193-202. PubMed ID: 20387911
    [Abstract] [Full Text] [Related]

  • 18. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR, Levy D, Crikelair N, Rocha R, Meng X, Glazer R.
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [Abstract] [Full Text] [Related]

  • 19. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations.
    Brixner DI, Jackson KC, Sheng X, Nelson RE, Keskinaslan A.
    Curr Med Res Opin; 2008 Sep; 24(9):2597-607. PubMed ID: 18812017
    [Abstract] [Full Text] [Related]

  • 20. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.